526 related articles for article (PubMed ID: 25938965)
1. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance.
Jeon JH; Lee JH; Lee JJ; Park KS; Karim AM; Lee CR; Jeong BC; Lee SH
Int J Mol Sci; 2015 Apr; 16(5):9654-92. PubMed ID: 25938965
[TBL] [Abstract][Full Text] [Related]
2. Decoding the Structural Basis For Carbapenem Hydrolysis By Class A β-lactamases: Fishing For A Pharmacophore.
Tondi D; Cross S; Venturelli A; Costi MP; Cruciani G; Spyrakis F
Curr Drug Targets; 2016; 17(9):983-1005. PubMed ID: 26424401
[TBL] [Abstract][Full Text] [Related]
3. Dual-tubed multiplex-PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp.
Kazi M; Nikam C; Shetty A; Rodrigues C
J Appl Microbiol; 2015 May; 118(5):1096-102. PubMed ID: 25647446
[TBL] [Abstract][Full Text] [Related]
4. Chemiluminescent Carbapenem-Based Molecular Probe for Detection of Carbapenemase Activity in Live Bacteria.
Das S; Ihssen J; Wick L; Spitz U; Shabat D
Chemistry; 2020 Mar; 26(16):3647-3652. PubMed ID: 31957167
[TBL] [Abstract][Full Text] [Related]
5. An enzoinformatics study for prediction of efficacies of three novel penem antibiotics against New Delhi metallo-β-lactamase-1 bacterial enzyme.
Ansari MA; Shaikh S; Shakil S; Rizvi SM
Interdiscip Sci; 2014 Sep; 6(3):208-15. PubMed ID: 25205498
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.
Ke W; Bethel CR; Thomson JM; Bonomo RA; van den Akker F
Biochemistry; 2007 May; 46(19):5732-40. PubMed ID: 17441734
[TBL] [Abstract][Full Text] [Related]
7. Carbapenemases: molecular diversity and clinical consequences.
Poirel L; Pitout JD; Nordmann P
Future Microbiol; 2007 Oct; 2(5):501-12. PubMed ID: 17927473
[TBL] [Abstract][Full Text] [Related]
8. A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem.
Garau G; Bebrone C; Anne C; Galleni M; Frère JM; Dideberg O
J Mol Biol; 2005 Jan; 345(4):785-95. PubMed ID: 15588826
[TBL] [Abstract][Full Text] [Related]
9. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
10. The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
Palacios AR; Mojica MF; Giannini E; Taracila MA; Bethel CR; Alzari PM; Otero LH; Klinke S; Llarrull LI; Bonomo RA; Vila AJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348667
[TBL] [Abstract][Full Text] [Related]
11. Update on the epidemiology of carbapenemases in Latin America and the Caribbean.
García-Betancur JC; Appel TM; Esparza G; Gales AC; Levy-Hara G; Cornistein W; Vega S; Nuñez D; Cuellar L; Bavestrello L; Castañeda-Méndez PF; Villalobos-Vindas JM; Villegas MV
Expert Rev Anti Infect Ther; 2021 Feb; 19(2):197-213. PubMed ID: 32813566
[TBL] [Abstract][Full Text] [Related]
12. [Enzymatic resistance to imipenem in gram-negative bacilli: NMC-A, an original carbapenemase].
Boyer-Mariotte S
Ann Pharm Fr; 1998; 56(6):244-9. PubMed ID: 9872010
[TBL] [Abstract][Full Text] [Related]
13. Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases.
Stewart NK; Smith CA; Frase H; Black DJ; Vakulenko SB
Biochemistry; 2015 Jan; 54(2):588-97. PubMed ID: 25485972
[TBL] [Abstract][Full Text] [Related]
14. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
15. The basis for carbapenem hydrolysis by class A β-lactamases: a combined investigation using crystallography and simulations.
Fonseca F; Chudyk EI; van der Kamp MW; Correia A; Mulholland AJ; Spencer J
J Am Chem Soc; 2012 Nov; 134(44):18275-85. PubMed ID: 23030300
[TBL] [Abstract][Full Text] [Related]
16. Structural and Functional Aspects of Class A Carbapenemases.
Naas T; Dortet L; Iorga BI
Curr Drug Targets; 2016; 17(9):1006-28. PubMed ID: 26960341
[TBL] [Abstract][Full Text] [Related]
17. Analysis of β-lactone formation by clinically observed carbapenemases informs on a novel antibiotic resistance mechanism.
Aertker KMJ; Chan HTH; Lohans CT; Schofield CJ
J Biol Chem; 2020 Dec; 295(49):16604-16613. PubMed ID: 32963107
[TBL] [Abstract][Full Text] [Related]
18. Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii.
Jeon JH; Hong MK; Lee JH; Lee JJ; Park KS; Karim AM; Jo JY; Kim JH; Ko KS; Kang LW; Lee SH
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):2924-36. PubMed ID: 25372683
[TBL] [Abstract][Full Text] [Related]
19. Evolution to carbapenem-hydrolyzing activity in noncarbapenemase class D β-lactamase OXA-10 by rational protein design.
De Luca F; Benvenuti M; Carboni F; Pozzi C; Rossolini GM; Mangani S; Docquier JD
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18424-9. PubMed ID: 22042844
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the enhanced carbapenemase efficiency of OXA-655 compared to OXA-10.
Leiros HS; Thomassen AM; Samuelsen Ø; Flach CF; Kotsakis SD; Larsson DGJ
FEBS Open Bio; 2020 Sep; 10(9):1821-1832. PubMed ID: 32683794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
